Latest News

Friday, November 21, 2014 | Earnings & Financials, Allergan, Valeant Ophthalmics

Valeant Slashes Stake in Allergan After Losing Bid

Valeant Pharmaceuticals International said it cut its stake in Allergan to 0.1 percent from 9.7 percent, three days after Actavis Plc trumped its offer for the Botox maker. Pershing Square Capital Man…

Read the full story

Friday, November 21, 2014 | Medical Studies

Telemedicine Screening for Diabetic Retinopathy Finds Condition in 1 of 5 Patients

A telemedicine program to screen for diabetic retinopathy (a leading cause of blindness) at urban clinics and a pharmacy predominantly serving racial/ethnic minority and uninsured patients with diabet…

Read the full story

Friday, November 21, 2014 | Clinical Trials

Further Scientific and Clinical Research Validating the Clinical Efficacy of 2RT for Early AMD Published

Ellex Medical Lasers Limited announced that additional positive scientific and clinical research on the therapeutic and safety profile of the company’s proprietary Retinal Rejuvenation (2R…

Read the full story

Friday, November 21, 2014 | Medical Studies

World’s Drug Bill Will Reach $1.3 Trillion in 2018: Study

Worldwide spending on medicines will reach almost $1.3 trillion by 2018, as new treatments for hepatitis C and cancer come to market and as people around the globe use rising incomes to buy pharmaceut…

Read the full story

Thursday, November 20, 2014 | Miscellaneous

$152,000 Raised to Help Blind and Visually Impaired at 2014 Eye Ball Gala

Passionate advocates for the blind and visually impaired as well as cornea transplant surgeons gathered at the 2014 Eye Ball Gala, raising $152,000 to help give the gift of sight. Each year, the Lions…

Read the full story

Thursday, November 20, 2014 | Clinical Trials

Drug Trial Results Can’t Be Hidden Under Proposed Rules

Pharmaceutical companies, medical device makers and academic medical centers would no longer be able to withhold the results of clinical trials under rules proposed by the U.S. Department of Health an…

Read the full story

Thursday, November 20, 2014 | Medical Studies

Identifying Eye Diseases by Studying Eye Movements of People Watching TV

One of the leading causes of blindness worldwide could be detected by how our eyes respond to watching TV according to a new study from researchers at City University London. The researchers, who were…

Read the full story

Thursday, November 20, 2014 | Medical Studies

Second-Eye Cataract Surgery Improves Quality of Life

Cataract surgery of the second eye improves the quality of life and visual function of the patient, above and beyond the benefits of the first eye surgery, a new study shows. From a socioemotional per…

Read the full story

Wednesday, November 19, 2014 |

CDC Report Connects Poor Contact Lens Care to Hundreds of Thousands of Eye Infections Each Year

A report released last week from the Centers for Disease Control and Prevention linked poor contacts lens use and hygiene habits to hundreds of thousands of eye infections per year, according to a new…

Read the full story

Wednesday, November 19, 2014 | Medical Studies

First-Born Children Have Better Vision, Research Shows

Birth order is thought to affect everything from a child's personality to IQ. Now researchers at the Illinois College of Optometry have concluded that birth order can also affect vision, according…

Read the full story

Wednesday, November 19, 2014 | Medical Studies

Novel Approach Found for Treating Number 1 Cause of Blindness in Elderly

While oxygen is essential to our planet's life force and the way we function and stay healthy, high concentrations referred to as oxidative stress may very well be the cause of more than 70 widely…

Read the full story

Wednesday, November 19, 2014 | Medical Studies

AMD Model May Predict Progression

A new statistical model may help ophthalmologists identify patients with age-related macular degeneration (AMD) who may progress from early or intermediate to more serious disease, according to an art…

Read the full story

Tuesday, November 18, 2014 | Acquisitions/Mergers, Allergan, Valeant Ophthalmics

Ackman Supports Allergan's $66 Billion Sale to Actavis

Pershing Square Capital Management on Tuesday formally withdrew its request for a special meeting of Allergan Inc. shareholders, another indication that the firm plans to end its pursuit of the Botox …

Read the full story

Tuesday, November 18, 2014 | Product Releases

Presbia Flexivue Microlens Receives Approval from Korean Ministry of Food and Drug Safety (MFDS)

Presbia announced that its Presbia Flexivue Microlens has received regulatory approval from the Korean Ministry of Food and Drug Safety (MFDS) making this new treatment option for the correction of ne…

Read the full story

Tuesday, November 18, 2014 | Medical Studies

Keratitis From Poor Contact Lens Care a Huge Burden in US

Eye infections, often resulting from improper contact lens use, send almost 1 million Americans to the doctor each year, federal health officials said today when releasing results of the first study t…

Read the full story
Load More

Advertisement

 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $25.03  0.00% 
 Akorn, Inc. $36.32  0.00% 
 Alimera Sciences, Inc. $5.37  0.00% 
 Allergan, Inc. $209.09  0.00% 
 Avalanche $34.64  0.00% 
 Bayer $145.66  0.00% 
 Can-Fite Biopharma $4.80  0.00% 
 Carl Zeiss Meditec $22.40  0.00% 
 Cooper Companies, Inc. $167.15  0.00% 
 Escalon Medical Corp. $1.43  0.00% 
 Essilor International $108.77  0.00% 
 Imprimis Pharmaceuticals, Inc. $8.34  0.00% 
 InSite Vision, Inc. $0.25  0.00% 
 IRIDEX Corporation $8.43  0.00% 
 Johnson & Johnson $107.86  0.00% 
 LCA-Vision Inc. $5.37  0.00% 
 Luxottica Group, S.p.A. $51.66  0.00% 
 Merck & Company, Inc. $59.66  0.00% 
 NicOx $2.06  0.00% 
 NovaBay Pharmaceuticals, Inc. $0.72  0.00% 
 Novartis AG Common Stock $94.98  0.00% 
 Ocular Therapeutix $15.54  0.00% 
 Ophthotech Corporation $40.81  0.00% 
 Quantel $3.34  0.00% 
 Regeneron $405.25  0.00% 
 Roche $37.29  0.00% 
 STAAR Surgical Company $9.15  0.00% 
 TearLab Corporation $2.76  0.00% 
 Thrombogenics $8.60  0.00% 
 Topcon Corporation $23.40  0.00% 
 Valeant Pharmaceuticals $145.37  0.00% 
 Xoma $4.59  0.00%